Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts.

被引：0
|
作者：
Somasundaram, Rajasekharan [1 ]
机构：
[1] Wistar Inst Anat & Biol, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.99
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Patient-derived xenografts as compatible models for precision oncology
    Sung-Yup Cho
    [J]. Laboratory Animal Research, 36
  • [42] Establishment of African American prostate cancer patient-derived primary cell lines and xenografts.
    Patierno, Brendon
    Glover, Wayne
    Ribar, Thomas
    Kittles, Rick
    Foo, Wen-Chi
    McCall, Shannon
    Huang, Jiaoti
    George, Daniel
    Freedman, Jennifer
    Patierno, Steven
    Wood, Kris
    Hsu, David
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 96 - 96
  • [43] Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies
    Odunsi, Adekunle
    McGray, A. J. Robert
    Miliotto, Anthony
    Zhang, Yali
    Wang, Jianming
    Abiola, Adebukola
    Eppolito, Cheryl
    Huang, Ruea-Yea
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [44] Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
    Kleinmanns, Katrin
    Gullaksen, Stein-Erik
    Bredholt, Geir
    Davidson, Ben
    Torkildsen, Cecilie Fredvik
    Grindheim, Sindre
    Bjorge, Line
    McCormack, Emmet
    [J]. CANCERS, 2022, 14 (13)
  • [45] A KRAS pathway activation index predicting response to MEK inhibitors in patient-derived tumor xenografts.
    Peille, Anne-Lise
    Maier, Armin
    Foucault, Frederic
    Krumbach, Rebekka
    Kees, Tim
    Giesemann, Torsten
    Metz, Thomas
    Metcalfe, Thomas
    Fiebig, Heinz-Herbert
    Vuaroqueaux, Vincent
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [46] Transcriptomic analysis of patient-derived xenografts reveals heterogeneity in human and mouse stroma/immune compartments
    Xue, Jia
    Qian, Wubin
    Guo, Sheng
    Cai, Jie
    Ouyang, Xuesong
    Li, Henry Qixiang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [47] Selumetinib-based therapy in uveal melanoma patient-derived xenografts
    Decaudin, Didier
    EL Botty, Rania
    Diallo, Bere
    Massonnet, Gerald
    Fleury, Justine
    Naguez, Adnan
    Dubois, Marine
    Davies, Emma J.
    Smith, Aaron
    Wilson, Joanne
    Howes, Colin
    Smith, Paul
    Cassoux, Nathalie
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Roman, Sergio Roman
    Nemati, Fariba
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [48] Leukaemia and lymphoma patient-derived xenografts (PDX) engraft on humanized mice and respond to immune therapy with check point inhibitors
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Siegert, Antje
    Brzezicha, Bernadette
    Sterner-Kock, Anja
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [49] Mouse clinical trial - A new preclinical study concept using patient-derived xenografts
    Vuaroqueaux, V.
    Gredy, C.
    Gorynia, S.
    Baltes, S.
    Fiebig, H. H.
    Metz, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 9 - 9
  • [50] Patient-derived tumour xenografts as models for oncology drug development
    Tentler, John J.
    Tan, Aik Choon
    Weekes, Colin D.
    Jimeno, Antonio
    Leong, Stephen
    Pitts, Todd M.
    Arcaroli, John J.
    Messersmith, Wells A.
    Eckhardt, S. Gail
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 338 - 350
12345